| 000 | 01633 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515193341.0 | ||
| 264 | 0 | _c20100308 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/cncr.24712 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInaba, Hiroto | |
| 245 | 0 | 0 |
_aCombination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bCancer _cJan 2010 |
||
| 300 |
_a98-105 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCladribine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRetreatment |
| 650 | 0 | 4 |
_aTopotecan _xadministration & dosage |
| 700 | 1 | _aStewart, Clinton F | |
| 700 | 1 | _aCrews, Kristine R | |
| 700 | 1 | _aYang, Shengping | |
| 700 | 1 | _aPounds, Stanley | |
| 700 | 1 | _aPui, Ching-Hon | |
| 700 | 1 | _aRubnitz, Jeffrey E | |
| 700 | 1 | _aRazzouk, Bassem I | |
| 700 | 1 | _aRibeiro, Raul C | |
| 773 | 0 |
_tCancer _gvol. 116 _gno. 1 _gp. 98-105 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cncr.24712 _zAvailable from publisher's website |
| 999 |
_c19274242 _d19274242 |
||